How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs

By AHRMM

John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products. 

Related Resources

Case Studies
Leading Practice: Vanderbilt University Medical Center's (VUMC) Collaborative, Data-Driven Approach to Opioid Management
AHRMM is building a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
White Papers
The Critical Link Between Cost, Quality, and Outcomes (CQO) and Unique Device Identification (UDI) White Paper
In an effort to capture broader insights on UDI adoption from across the health care field, AHRMM, with participation by the FDA, held LUC Dat
Webcast
The Expansion of Health Care Delivery Methods and Supply Chain Considerations Webcast
Explore the new delivery methods of health care, how community resources and organizations are now working together to reduce patient episodic
e-Learning
CMRP Review eLearning Course Bundle
Webcast
Webcast: A New Hospital Economic Index: Join on the Ground Level
This short webcast will give you a brief overview of the current ISM® Report On Business, share details surrounding the development of the new
Webcast
UDI: Value Beyond Compliance Recording
Karen Conway, executive director of industry relations and value at GHX discusses her research with the FDA on the value of UDI adoption with Mike…